NCT00522067View on ClinicalTrials.gov

Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Influenza Disease
Interventions
BIOLOGICAL

Adjuvanted influenza vaccine

Vaccination with MF 59 adjuvanted trivalent seasonal influenza vaccine

Trial Locations (1)

53100

Azienda Sanitaria USL 7 di Siena, Siena

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY

NCT00522067 - Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases. | Biotech Hunter | Biotech Hunter